NCT00001730View on ClinicalTrials.gov

Study of Radioiodine (131-I) Uptake Following Administration of Thyrogen and Hypothyroid States During Thyroid Hormone Withdrawal.

PHASE4CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

December 31, 1997

Study Completion Date

April 30, 2000

Conditions

HypothyroidismThyroid Neoplasms

Interventions

DRUG

Thyrogen

Trial Locations (1)

20892

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), Bethesda

All Listed Sponsors

lead

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

NIH

NCT00001730 - Study of Radioiodine (131-I) Uptake Following Administration of Thyrogen and Hypothyroid States During Thyroid Hormone Withdrawal. | Biotech Hunter | Biotech Hunter